The Evolving Landscape of Pharmacoeconomics in the Era of Pharmacogenomics
As the field of medicine continues to advance, the convergence of pharmacoeconomics and pharmacogenomics has become increasingly important in delivering cost-effective, personalised healthcare. Pharmacoeconomics aims to assess the costs and benefits associated with various treatment strategies, while pharmacogenomics focuses on identifying genetic markers that influence an individual’s response to drugs. This blog explores the role […]
The Evolving Landscape of Pharmacoeconomics in the Era of Pharmacogenomics Read More »